Enter assignee name

Forward Citations = 10

Loading Chart...

5 inventors (with patents filed for the assignee):

Christopher D Thanos (9 out of 60 patents)

Laura Hix Glickman (9 out of 16 patents)

Justin Skoble (7 out of 12 patents)

4. Alexandre Charles Michel Iannello (5 out of 5 patents)

5. Haixing Kehoe (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 12553047 - ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF (2026-02-17),

2. 12357661 - Engineered immunostimulatory bacterial strains and uses thereof (2025-07-15),

3. 12226439 - Engineered immunostimulatory bacterial strains and uses thereof (2025-02-18),

4. 12201653 - Engineered immunostimulatory bacterial strains and uses thereof (2025-01-21),

5. 12024709 - Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment (2024-07-02),

6. 12012600 - Engineered immunostimulatory bacterial strains and uses thereof (2024-06-18),

7. 11779612 - Engineered immunostimulatory bacterial strains and uses thereof (2023-10-10),

8. 11242528 - Engineered immunostimulatory bacterial strains and uses thereof (2022-02-08),

9. 11168326 - Engineered immunostimulatory bacterial strains and uses thereof (2021-11-09),

Actym Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Our mission is to improve the lives of patients by advancing innovative treatments that target the underlying causes of autoimmune disorders. With a dedicated team of researchers and scientists, Actym Therapeutics is committed to making a positive impact in the field of autoimmune healthcare.

Profile summary based on public USPTO records.